Pharmaceutical Executive Editorial Staff

In the wake of the COVID-19 pandemic, pharmaceutical brand names across the world have surged in value as they have become household names globally, according to a new report from leading brand valuation consultancy Brand Finance.

Programmatic campaigns conducted on the DeepIntent platform are now guaranteed to reach verified patient audiences for specific health conditions across CTV, display, and digital video.

Healthcare Providers (HCPs), also every day consumers of digital information, have not been satisfied with the level of engagement delivered by pharma in comparison to other industries. Pharm Exec chats with Matt Titus, CCO of Epocrates, about the key role Non-Personal Promotion (NPP) plays in an omnichannel approach.

Common data architecture helps connect sales, medical, and marketing for commercial excellence.

The Four are Veeva Link for Key Accounts, Scientific Awareness, Medical Insights, and Veeva Link+

Mr. Garnett is a serial entrepreneur and corporate executive with many years of success in founding and leading consumer-packaged-goods and beverage companies in Canada and the United States.

Global Biopharmaceutical Company Hires Leading PR Firm as it Expands Their U.S. Operations.

Over the course of his career, Mr. Pidduck has been involved in the successful ground-up commercialization of several products in both Canadian and international markets and brings a track record of both organic execution as well as M&A and integration expertise.

Boehringer Ingelheim and Lilly launch Hear Your Heart™, an empowering health initiative to provide resources and education for women with heart failure, especially Black and Latina women, to help optimize their care.

Flutura to deploy Cerebra Digital Twin & Pharmacologist Workbench, a self-service AI platform to accelerate impact to Pharmaceutical outcomes.

Bringing together Bristol Myers Squibb and Celgene on one clinical trial management system, company goes live with Vault CTMS in record speed. Modernization streamlines trial management to speed medicines to patients.

Rick Livesay brings over 25 years of healthcare experience to the company to bolster Nava's San Francisco presence.

By acquiring Monkeys not Donkeys, QbD will strengthen its "from idea to patient" offering.

The agreement will expand Univar Solutions' diverse excipient portfolio, helping customers with drug delivery in Brazil and Mexico.

In his new role, Avallone will be responsible for growing the Evoke data team, expanding their data offerings around audience insights and analytics, and providing high-value consultancy to clients.

Award-winning Healthcare IT PR agency to collaborate with leader in modernizing payer workflows to amplify client successes and industry best practices.

Rebecca will work across the VUE Health companies, including its cross-cultural arm Latitude Health.

The appointment reinforces the global healthcare communications network commitment to its ‘Power of One’ model.

The acquisition creates an end-to-end pharmaceutical product commercialization and launch excellence capability that optimizes and accelerates patient access to medical advances.

Miller joins as the Chief Business Officer/Chief Operating Officer, bringing decades of corporate strategy and business development experience in the biotech and pharmaceutical industries.

Foster talks to Pharm Exec about why liver disease is on the rise, and Hepion’s new therapy, rencofilstat, in development to treat it.

Pharma trailblazer will accelerate growth at COTA with a focus on advancing real-world data use in drug development, increasing diversity in clinical trials, and supporting the move to data-driven, value-based cancer care.

The collaboration leverages Insilico's end-to-end AI-driven Pharma.AI platform to discover novel small molecule drug candidates for multiple targets, along with EQRx's innovative business model to accelerate drug development and patient access to novel medicines at affordable prices.

Genomic data is transforming precision medicine—but progress depends on it being easily available where it’s needed. Pharmaceutical Executive speaks to Ignacio Medina, founder of Cambridge University spinout Zetta Genomics, to see how next-generation open-source data technologies accelerate discovery in the lab and patient benefit in the clinic.

Augustin, a Senior Creative Strategist at Artemis Ward, leads the PhRMA account and provides a strategic lens to the overall work.

Rush shares his thoughts on how advanced analytics are making their mark on the pharma industry.

OCE+ is the first of several new advancements to IQVIA's leading life science customer engagement platform.

In this newly created role, Peter will drive the overall impact of the agency’s work by infusing breakthrough creativity and insight-informed strategy across the business.

Brennan describes what her career journey in pharma has looked like as a woman, and what she feels can be done to improve opportunities for other females in pharma. She also talks about how advocacy and commitment can similarly be applied to improve the rare disease space.

Mazur talks about his commitment to drug development and what it takes to succeed in the industry today.